SmartPakSmartPak
  • USEF Network Andres Rodriguez & Darlon van Groenhove win the $40,000 Hollow Creek Farm CSI3* Grand Prix #SRJT 5/22/2015 6:40:06 PM
  • USEF Network David Beisel & Ammeretto has an unfortunate rail at the last with a time of 33.56 5/22/2015 6:36:59 PM
  • USEF Network Margie Engle & Royce are clear and currently in second with a time of 34.67 5/22/2015 6:35:06 PM
  • USEF Network Andres Rodriguez & Darlon van Groenhove take over the lead with a clear round and a time of 33.51 5/22/2015 6:31:40 PM
  • USEF Network Ali Wolff and Brianda are clear with a time of 36.23, moving into the lead 5/22/2015 6:29:48 PM
  • USEF Network Meagan Nusz and Leoville 2 have a rail and a time of 41.02 5/22/2015 6:27:39 PM
  • USEF Network Brian Walker and Best Wishes have a rail and a time of 37.02 5/22/2015 6:25:41 PM
  • USEF Network Pablo Barrios and Zara Leandra knock a rail in the jump off 5/22/2015 6:24:12 PM
  • USEF Network @rachuq and Versus have a time 36.39 and are clear 5/22/2015 6:23:05 PM
  • USEF Network The jump-off for the $40,000 Hollow Creek Farm CSI3* Grand Prix is just moments away at the @SRJumpingTour 5/22/2015 6:15:24 PM

News

Adequan Supply Update

RELEASE: September 17, 2013
AUTHOR/ADMINISTRATOR: Adequan

Shirley, NY- Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® IM, Adequan® IA, and Adequan® Canine provides the following supply update:

We are pleased to announce a shipment of Adequan® (polysulfated glycosaminoglycan) IM was released to the market last week and was received by veterinarians beginning Friday, September 13th . Adequan® product supply remains limited and the initial shipments will not fully satisfy market demand. Luitpold made significant investments in upgrading its manufacturing facilities earlier this year. The time spent making these upgrades impacted our ability to keep up with demand. We are working diligently to release additional product to the market and will provide updates as they become available. Quality and integrity remain our highest priorities.

We encourage Adequan® users to continue to work with their veterinarians to obtain the drug and discuss the most appropriate treatment regimen for your animals.

Luitpold has established a dedicated webpage on www.adequan.com where concerned parties can register to receive future communications and updates on this matter. You may also contact our Customer Service Department at 1-800-458-0163.

Adequan® IM and IA are the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses. Adequan® Canine is the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.

News

Competitions